Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03448666 |
Title | ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases |
Recruitment | Withdrawn |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | European Institute of Oncology |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | ITA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
IEO Istituto Europeo di Oncologia | Milan | 20141 | Italy | Details |